Clinical Trial Update: HEALEY ALS Platform Trial - Master Protocol [Phase 2, Phase 3]

View source ↗

Summary

HEALEY ALS Platform Trial master protocol for Phase 2 and Phase 3 arms in amyotrophic lateral sclerosis. Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Snippet

Sponsor: Merit E. Cudkowicz, MD | Conditions: Amyotrophic Lateral Sclerosis | Phase 2, Phase 3 | Status: RECRUITING